• AGC Biologics and Oculis Enter Manufacturing Deal contractpharma
    May 08, 2021
    ​AGC Biologics, a global biopharmaceutical contract development and manufacturing organization (CDMO), has entered a partnership with Oculis to manufacture OCS-02, a Phase II investigational drug targeting both Dry Eye Disease and Anterior Uveitis ...
PharmaSources Customer Service